AbbVie
ABBV
#25
Rank
$514.92 B
Marketcap
$291.31
Share price
1.07%
Change (1 day)
33.19%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of June 2026 : -$5.89 Billion USD

According to AbbVie's latest financial reports the company has -$5.89 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$10.39 B-39.86%
2022-12-31$$17.28 B11.99%
2021-12-31$$15.43 B17.86%
2020-12-31$$13.09 B-260.27%
2019-12-31$-$8.18 Billion-3.24%
2018-12-31$-$8.45 Billion-265.71%
2017-12-31$$5.09 B9.94%
2016-12-31$$4.63 B17.52%
2015-12-31$$3.94 B126.46%
2014-12-31$$1.74 B-61.22%
2013-12-31$$4.49 B33.57%
2012-12-31$$3.36 B-71.82%
2011-12-31$$11.93 B-24.01%
2010-12-31$$15.70 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
$85.49 B-1,551.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$40.27 B-783.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$11.68 B-298.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$18.84 B-420.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$11.74 B-299.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$23.40 B-497.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$50.37 B-955.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$24.35 B-513.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$3.69 B-162.73%๐Ÿ‡บ๐Ÿ‡ธ USA